Skip to main content

Advertisement

Log in

The role of myeloid derived suppressor cells in mycosis fungoides

  • Letter to the Editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

A Letter to the Editors to this article was published on 04 April 2018

The Original Article was published on 04 December 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Geskin LJ, Akilov OE, Kwon S, Schowalter M, Watkins S, Whiteside TL, Butterfield LH, Falo LD Jr (2018) Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. Cancer Immunol Immunother 67(3):423–434. https://doi.org/10.1007/s00262-017-2090-z

    Article  PubMed  CAS  Google Scholar 

  2. Pileri A, Agostinelli C, Sessa M, Quaglino P, Santucci M, Tomasini C, Grandi V, Fava P, Astrua C, Righi S, Patrizi A, Pileri SA, Pimpinelli N (2017) Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. Virchows Arch 470(5):575–582. https://doi.org/10.1007/s00428-017-2107-1

    Article  PubMed  CAS  Google Scholar 

  3. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174. https://doi.org/10.1038/nri2506

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Sasso MS, Lollo G, Pitorre M, Solito S, Pinton L, Valpione S, Bastiat G, Mandruzzato S, Bronte V, Marigo I, Benoit JP (2016) Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy. Biomaterials 96:47–62. https://doi.org/10.1016/j.biomaterials.2016.04.010

    Article  PubMed  CAS  Google Scholar 

  5. He W, Liang P, Guo G, Huang Z, Niu Y, Dong L, Wang C, Zhang J (2016) Re-polarizing myeloid-derived suppressor cells (MDSCs) with cationic polymers for cancer immunotherapy. Sci Rep 6:24506. https://doi.org/10.1038/srep24506

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandro Pileri.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

This comment refers to the article available at https://doi.org/10.1007/s00262-017-2090-z.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pileri, A., Agostinelli, C., Quaglino, P. et al. The role of myeloid derived suppressor cells in mycosis fungoides. Cancer Immunol Immunother 67, 1175–1176 (2018). https://doi.org/10.1007/s00262-018-2153-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-018-2153-9

Navigation